Thomas Eppes
Family Medicine · Forest, VANPI 1700869906
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,316 and has fallen 98.9% since, to $14 in 2025.
Across 319 payments — averaging $13.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$896
- Johnson & Johnson$515
- AstraZeneca$332
- Amgen$283
- Pfizer$278
- GSK$266
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,395100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 77 | $896 |
| Johnson & Johnson | 51 | $515 |
| AstraZeneca | 11 | $332 |
| Amgen | 15 | $283 |
| Pfizer | 32 | $278 |
| GSK | 22 | $266 |
| Lilly USA, LLC | 11 | $197 |
| Boehringer Ingelheim | 11 | $184 |
| Merck | 10 | $149 |
| AbbVie | 8 | $142 |
| Esperion Therapeutics, Inc. | 8 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $131 |
| Abbott | 5 | $103 |
| Sanofi-aventis U.S. LLC | 7 | $99 |
| Teva Pharmaceuticals USA, Inc. | 6 | $89 |
| Astellas Pharma US Inc | 5 | $86 |
| Amarin Pharma, Inc. | 5 | $86 |
| Genentech USA, Inc. | 6 | $85 |
| Novartis | 4 | $62 |
| Dexcom, Inc. | 2 | $42 |
| Eisai Inc. | 3 | $40 |
| Bayer | 3 | $40 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Radius Health, Inc. | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$113
How this compares
$4,401 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Forest
- Manuel PeraltaForest$15K
- Mark KleinerForest$15K
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.